Literature DB >> 15993587

Ketoheterocycle-based inhibitors of cathepsin K: a novel entry into the synthesis of peptidic ketoheterocycles.

Francis X Tavares1, David N Deaton, Aaron B Miller, Larry R Miller, Lois L Wright.   

Abstract

Ketoheterocyclic inhibitors of cathepsin K have been disclosed. SAR of potency enhancing P2-P3 groups coupled with ketoheterocyclic warheads to provide cathepsin K inhibitors have been described. In addition, a novel route to access alpha-ketothiazoles using a key thioamide functionality has been disclosed. The mild method employed allows for the presence of diverse functional groups, such as amide and carbamate functionalities, commonly found in protease inhibitors that have peptidomimetic scaffolds. This new method should provide a quick entry into functionally diverse protease inhibitors.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15993587     DOI: 10.1016/j.bmcl.2005.05.091

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  3 in total

1.  α-ketoheterocycles as inhibitors of Leishmania mexicana cysteine protease CPB.

Authors:  Koen Steert; Maya Berg; Jeremy C Mottram; Gareth D Westrop; Graham H Coombs; Paul Cos; Louis Maes; Jurgen Joossens; Pieter Van der Veken; Achiel Haemers; Koen Augustyns
Journal:  ChemMedChem       Date:  2010-10-04       Impact factor: 3.466

Review 2.  Cathepsin K inhibitors for osteoporosis and potential off-target effects.

Authors:  Dieter Brömme; Fabien Lecaille
Journal:  Expert Opin Investig Drugs       Date:  2009-05       Impact factor: 6.206

3.  Comprehensive Analysis of Structure-Activity Relationships of α-Ketoheterocycles as sn-1-Diacylglycerol Lipase α Inhibitors.

Authors:  Freek J Janssen; Marc P Baggelaar; Jessica J A Hummel; Herman S Overkleeft; Benjamin F Cravatt; Dale L Boger; Mario van der Stelt
Journal:  J Med Chem       Date:  2015-12-02       Impact factor: 7.446

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.